RevMAb生物科学美国公司开发了一种革命性的单克隆抗体生成方法，它允许在不产生杂交瘤的情况下开发单克隆抗体。

RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. Our mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis. We seek to accomplish this by providing superior monoclonal antibodies to our customers in the research and diagnostic fields.